Breakthrough T1D T1D Fund Invests in vTv Therapeutics
With an investment from the Breakthrough T1D T1D Fund, vTv Therapeutics will run a phase III clinical trial of cadisegliatin…
World-Renowned Researchers Gather at the Breakthrough T1D-nPOD Annual Meeting
Leading researchers gathered in Long Beach, California, for the 16th annual meeting of the Network for Pancreatic Organ Donors with…
Bench to Bedside: Breakthrough T1D-nPOD Conference
Leading scientists will gather for the annual meeting of the Network for Pancreatic Organ Donors with Diabetes (nPOD), held February…
We are Grateful to be a Part of the T1D Community
In 2023, we have made tremendous progress in accelerating cures, improving lives, and advocating for people with T1D and their…
FDA-Approved Immune Therapy Shows Benefit in Newly Diagnosed
In a Breakthrough T1D-funded clinical trial and published in the New England Journal of Medicine, baricitinib preserved beta cell function…
ISPAD Annual Conference Highlights Include Tzield, Kidney Disease Clinical Trial Updates
Leading diabetes researchers gathered for the annual ISPAD conference. More than 45 studies were presented by Breakthrough T1D researchers, including…
Results Are Out: Tzield Benefits Newly Diagnosed Individuals
A new study published in the New England Journal of Medicine shows Tzield can preserve beta cell health in certain…
Top Diabetes Researchers Gather for the ISPAD Annual Conference
Leading researchers from around the world will gather for the ISPAD annual conference, with more than 45 studies presented by…
EASD Meeting Brought Together World-Renowned Minds in Diabetes Research
Leading researchers gathered for the annual meeting of the European Association for the Study of Diabetes (EASD), which took place…
Top Researchers Gather for the EASD Annual Meeting
Leading researchers will gather for the annual meeting of the European Association for the Study of Diabetes, with 65 presentations…
